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Abstract
The importance of cell phenotype in determining the molecular mechanisms underly-
ing β2- adrenoceptor (β2AR) function has been noted previously when comparing re-
sponses in primary cells and recombinant model cell lines. Here, we have generated 
haplotype- specific SNAP- tagged β2AR human embryonic stem (ES) cell lines and 
applied fluorescence correlation spectroscopy (FCS) to study cell surface receptors 
in progenitor cells and in differentiated fibroblasts and cardiomyocytes. FCS was 
able to quantify SNAP- tagged β2AR number and diffusion in both ES- derived car-
diomyocytes and CRISPR/Cas9 genome- edited HEK293T cells, where the expres-
sion level was too low to detect using standard confocal microscopy. These studies 
demonstrate the power of FCS in investigating cell surface β2ARs at the very low ex-
pression levels often seen in endogenously expressing cells. Furthermore, the use of 
ES cell technology in combination with FCS allowed us to demonstrate that cell sur-
face β2ARs internalize in response to formoterol- stimulation in ES progenitor cells 
but not following their differentiation into ES- derived fibroblasts. This indicates that 
the process of agonist- induced receptor internalization is strongly influenced by cell 
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1 |  INTRODUCTION
The β2- adrenoceptor (β2AR) is a prototypical member of the 
class A family of G protein- coupled receptors (GPCRs).1 
Crystal structures of the active β2AR bound to the partial 
agonist salmeterol or the native hormone adrenaline, with ei-
ther a Gs protein or active state- stabilizing nanobodies, have 
greatly advanced understanding of the pharmacology and ac-
tivation of β2ARs.2- 5 Upon ligand stimulation β2ARs prefer-
entially bind to the heterotrimeric G- protein Gαs, stimulating 
the activation of adenylyl cyclase to catalyze the formation of 
cyclic AMP from ATP.6 Cell surface signaling is terminated 
following the phosphorylation of the C- terminal domain of 
the β2AR by G- protein receptor kinases (GRK), signpost-
ing the receptor for beta- arrestin mediated internalization.7- 9 
This can lead to a second phase of signaling from intracel-
lular endosomes.10,11 The β2AR undergoes ligand- directed 
internalization via a clathrin- mediated and Rab 5- regulated 
constitutive endocytic pathway for recycling alongside trans-
ferrin, but can also localize to lysozymes if directed toward a 
degradation pathway.12- 16
The β2AR has been shown to display distinct trafficking 
profiles dependent on the presence of single- nucleotide poly-
morphisms (SNPs).17- 20 While there are a number of SNPs 
present in the human β2AR only four result in altered amino 
acids; Arg16Gly, Glu27Gln, Val34Met, and Thr164Ile.21- 23 
Within the human population, Arg16Gly and Glu27Gln are 
most common and these are present in the N- terminus re-
gion.18,19 The relative frequency of these genotypes within 
the human population varies with race24; however, linkage 
disequilibrium leads to the Arg16Glu27 haplotype being ex-
tremely rare.25
Cell phenotype has been shown to be important in deter-
mining the nature of the molecular mechanisms underlying 
β2AR function and regulation.7,14,26 For instance, responses 
to βAR agonists differ dramatically between primary vascu-
lar smooth muscle cells and recombinant HEK293 systems.26 
Similarly, clustering of β2ARs has been demonstrated in 
cardiomyocyte- like rat H29C cells but not in HeLa or CHO 
cell lines.14 Cell type specificity is likely to be dictated by 
the expression levels of both the β2AR and its effector pro-
teins, as observed in the case of the GRK subtype responsible 
for β2AR phosphorylation.7 To determine these molecular 
mechanisms, single- molecule imaging techniques have been 
employed which have the sensitivity necessary to expose the 
spatial and temporal characteristics of these short- lived ef-
fects.27- 31 Coupling of single- molecule imaging techniques 
with the use of human embryonic stem (ES) cells, that can 
be induced to differentiate into multiple cell phenotypes, pro-
vides a potential approach to study the impact of cell pheno-
type on receptor pharmacology.32- 34
An important consideration is the need to work at low re-
ceptor expression levels similar to those seen endogenously 
to limit the impact of receptor over- expression.35,36 A draw-
back of imaging endogenous GPCRs using standard light 
microscopy within their native environment; however, is 
that low levels of endogenous receptor expression can lead 
to poor signal to noise ratios.37,38 One approach with the 
sensitivity to monitor receptors in membrane microdomains 
at very low receptor expression levels is fluorescence cor-
relation spectroscopy (FCS). 39- 44 Here, we have generated 
haplotype- specific SNAP- tagged β2AR human ES cell lines 
and applied FCS to monitor cell surface receptors in differen-
tiated fibroblasts and cardiomyocytes.
2 |  METHODS
2.1 | Creation of SNAPβ2AR construct
To create the pSIN- B2- BSD(RQ) lentiviral construct we 
PCR amplified the Arg16Gln27 (RQ) variant of SNAPβ2AR 
from the pcDNA3.1(Neo+)sig.SNAP(Met  >  Leu mutant) 
expression vector45 with the following primer pairs: Fwd1- 
CTTAAaCTaGtTACCGCCACCATGCGGCTCTGC and 
Rev1- TCTGCAGAATTCTTACAGCAGTGAGTCATTTG, 
and after digestion with SpeI and EcoRI restriction enzymes 
cloned it into the SpeI/EcoRI pSIN- BSD lentiviral vector 
backbone produced from the pSIN- GFP- BSD plasmid.46 All 
remaining haplotypes variants were created by a PCR- splice 
mutagenesis technique47 using the pSIN- B2- BSD(RQ) con-
struct as a template, with the following set of overlapping prim-
ers: G79C Fwd 5′- CGTCACGCAGGAAAGGGACGAG- 3′ 
& G79C Rev 5′- CTCGTCCCTTTCCTGCGTGACG 
for changing position 79 of β2AR; and G48A Fwd 
5′- CTGGCACCCAATGGAAGCCATG & G48A Rev 
phenotype and this may have important implications for drug treatment with long- 
acting β2AR agonists.
K E Y W O R D S
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5′- ATGGCTTCCATTGGGTGCCAG, for substituting 
A for G at position 48 of β2AR. The following two prim-
ers were used as flanking primers for all PCR- splice reac-
tions: Fwd2- CATTCTCAAGCCTCAGACAGTGG and 
Rev2 5′- AAATCACATATAGACAAACGCACAC. The 
final PCR products for each corrected SNP variant were 
SpeI/EcoRI digested and cloned into the pSIN- BSD SpeI/
EcoRI backbone as described above. In total three vectors 
were produced from pSIN- B2- BSD(RQ) which were: pSIN- 
B2- BSD(RE), pSIN- B2- BSD(GQ), and pSIN- B2- BSD(GE) 
which represent the four different haplotypes involving the 
single- nuclear polymorphisms at Arg16Gly and Glu27Gln. 
In order to generate lentiviral particles, each construct was 
transfected together with packaging vectors in to a BL15 
cell line and the particles produced were purified on strepta-
vidin paramagnetic beads (Promega) as described in detail 
earlier.48,49 Purified viral particles were used to transduce 
HEK293T and HUES7 cell lines at MOI of 10. Twenty- four 
hours following transduction, growth media was exchanged 
for fresh medium and after 48  hours Blasticidin (Thermo 
Fisher Scientific) was added to the media at a concentration 
of 2.5 μg/mL for HEK293T and 2 μg/mL for HUES7 cells. A 
population of antibiotic- resistant cells was expanded in cul-
ture for 3 weeks before being banked for further experimental 
use.
2.2 | CRISPR/Cas9 genome- engineering of 
HEK293T cells
Generation of constructs for CRISPR/Cas9 genome- 
engineering of the N- terminal region of the β2AR genomic 
locus was performed as described previously16 with the 
following modification: Following synthesis of the β2AR 
donor repair template, sig- SNAP45 was ligated into the repair 
template using the restriction enzymes KpnI and BamHI. A 
mutation introduced during the synthesis of the donor repair 
template to eliminate an internal KpnI restriction site was 
then corrected by site- directed mutagenesis using primers de-
scribed previously.16 The donor template, therefore, resulted 
in cells expressing genome- edited sig- SNAPβ2AR with the 
start codon (Met) of the β2AR deleted.
CRISPR/Cas9 genome- engineering of the β2AR ge-
nomic locus in HEK293T was performed as described pre-
viously.50 Briefly, HEK293T cells were seeded into six well 
plates and incubated for 24 hours at 37°C/5% CO2. HEK293T 
cells were cultured in DMEM supplemented with 10% fetal 
bovine serum (FBS). At 60% confluency, cells were trans-
fected with px459 sgRNA/Cas9 expression constructs16 and 
the donor repair template encoding sig- SNAPβ2AR using 
FuGENE transfection reagent (Promega). Twenty- four hours 
later cells were cultured with puromycin (0.3 µg/mL, Sigma- 
Aldrich) for 3 days. Following selection, cells were cultured 
without puromycin and seeded into clear flat bottom 96- well 
plates at 1 cell per well and allowed to expand for 2- 3 weeks. 
Single colonies were then seeded into duplicate 48 well 
plates and allowed to expand. To screen for positive clones, 
genomic DNA was extracted using a Wizard Genomic DNA 
Purification Kit (Promega) and PCR performed using the 
following primers 5′- CGAGTGTGCTGAGGAAATCA- 3′ 
and 5′- CGCCAGAGCTAGACACCAC- 3′. The primers used 
were designed to anneal outside the left homology arm of 
the donor repair template and the SNAP tag, respectively. 
Positive clones were expanded prior to use.
2.3 | Cell culture
Transgenic and non- transgenic HEK293T cells were main-
tained in growth media at 37ºC 5% CO2; Dulbecco modified 
eagles medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS). In the case of transgenic lines, the growth me-
dium also contained blasticidin (2.5 μg/mL). Once confluent, 
cells were dislodged from the flask surface by gentle shaking 
after incubation in 0.25% trypsin and a cell pellet formed fol-
lowing 5 minutes 1000 g centrifugation. For subsequent as-
says, cells were re- suspended in DMEM supplemented with 
10% FBS and seeded at a density of 40- 50 000 cells/well on 
poly- D- lysine treated clear- bottomed white- walled (radioli-
gand binding), black- walled (internalization assay) 96 well 
plates or 8- well Nunc Lab- tek chambered coverglass (No. 1.0 
borosilicate glass bottom) (imaging). Cells were incubated at 
37ºC 5% CO2 overnight prior to assay.
The human embryonic stem cell line, HUES7 (ES), was 
gifted from Harvard University under Material Transfer 
Agreement51 and approved for use by the UK Stem Cell 
Steering Committee (Ref no 17/12/2007). Undifferentiated 
cells were cultured under feeder- free conditions on Matrigel- 
coated surfaces in the presence of MEF (mouse embryonic 
fibroblast) conditioned medium supplemented with 4  ng/
mL of bFGF (basic fibroblast growth factor), as previously 
described.34,49 Transgenic haplotype variant lines were 
maintained in the same conditions in presence of 2 μg/mL 
of blasticidin in order to maintain the expression level of 
transgenes. For monolayer differentiation into cardiomyo-
cytes, cells were first transitioned to the E8 culture medium 
(Life Technologies) and banked, and then differentiated as 
previously described.52 Fibroblast differentiation was as fol-
lows: Transgenic cell lines were first seeded at 40 000 cells/
cm2 in a Matrigel- coated T25 flask and cultured in Essential 
8 medium until reaching 80% confluence. The culture was 
then treated with StemPro34 (Life Technologies) medium 
supplemented with 10  ng/mL of BMP4 (bone morphoge-
netic protein 4, R&D systems) and 8  ng/mL of Activin A 
(Life Technologies) and cultured for 48  hours; on day 2, 
the medium was switched into RPMI medium added with 
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B27 supplement and 10% FBS; on day 4, the medium was 
changed into the fibroblast culture medium, which containing 
DMEM supplemented with 10% FBS, 1X GlutaMAX and 1X 
NEAA (non- essential amino acids). Differentiation into spe-
cific cell types was confirmed by immunohistochemistry to 
identify cell type- specific markers (Supporting Information 
Figure S1).
2.4 | Radioligand binding
Cells were plated at densities of 50  000 (HEK293T) or 
70 000 (ES) cells per well in white- walled, clear- bottomed 
96 well plates in growth media and left overnight. Growth 
media was aspirated and cells were incubated in 100  µL 
serum- free media (HEK293T:DMEM; ES: RPMI condi-
tioned media supplemented with B27 supplement (Life 
Technologies)) in the presence or absence of 10 pM- 10 µM 
of CGP 12177, CGP 20712A, ICI 118551 or propranolol 
(for competition binding assays), and the presence or ab-
sence of 10 µM propranolol (for saturation binding assays). 
The addition of 100 µL of serum- free medium or serum- 
free medium containing 0.01- 20 nM (saturation) 3H- CGP 
12177 immediately followed and cells were incubated for 
2 hours at 37°C 5% CO2. Cells were washed twice in PBS 
(Phosphate Buffered Saline) and 200  µL Microscint 20 
added to each well and a white bottom and a topseal added 
to each plate. Plates were then left overnight and readings 
taken (counts per minute; CPM) on a TopCount Microplate 
Scintillation Counter (Packard Instrument, CT).
2.5 | SNAP labeling
The SNAP- tag labeling system allows real- time live- cell 
imaging of the protein of interest following labeling of the 
20 kDa SNAP- tag which can be engineered to be expressed 
on the N- or C- terminus of the protein. The SNAP- tag rep-
resents O6- alkylguanine- DNA alkyltransferase that reacts 
specifically and rapidly with benzylguanine (BG) derivatives 
resulting in an irreversible covalent linking with a fluorescent 
probe.53 Cells were incubated in growth medium in the pres-
ence of 0.5 µM (imaging), 0.1- 2 µM (internalization assay) 
or 0.1  µM (fluorescence correlation spectroscopy; FCS) 
SNAP- Surface Alexa Fluor 488 (SNAP- 488) for 30  min-
utes at 37°C. Following this, cells were then washed twice 
in warmed appropriate imaging buffer. HBSS (HEPES- 
buffered saline solution pH 7.45; Sodium pyruvate 2  mM, 
NaCl 145 mM, D- Glucose 10 mM, KCl 5 mM, MgSO4.7H2O 
1 mM, HEPES 10 mM, CaCl2 1.7 mM, NaHCO3 1.5 mM) 
was used for HEK293T cells. ES- HBSS (HEPES- buffered 
saline solution pH 7.45; NaCl 140 mM, D- Glucose 10 mM, 
KCl 4  mM, MgCl2 1  mM, HEPES 10  mM) was used for 
ES progenitor cells, ES- derived fibroblasts, and ES- derived 
cardiomyocytes.
2.6 | Confocal microscopy
Cells were plated at varying densities on 8- well Nunc Lab- 
tek chambered coverglasses in growth media and left over-
night. Slides were pre- coated with poly- D- lysine (HEK293T) 
or Matrigel (ES progenitor cells and cardiomyocytes) or 
used without pre- coating in the case of fibroblasts. The fol-
lowing day the media was removed and cells were SNAP 
labeled with SNAP- Surface Alexa Fluor 488 (SNAP- 488) 
as described above. Cells were imaged on either the Zeiss 
LSM710 or Zeiss LSM880 confocal microscopes, both with 
a Zeiss Axio Observer Z1 stand (Carl Zeiss, Germany) using 
488 nm Argon laser excitation (to image SNAP- 488), a 493- 
630 nm emission range, and a plan- apochromat 40× 1.2NA 
oil immersion objective. Pinhole was set at 1 airy unit and 
gain and offset settings were kept constant within the experi-
mental day. Cells were imaged in the presence or absence of 
formoterol and processed using Zen Black (2012) software 
(Carl Zeiss, Germany).
2.7 | Immunocytochemistry
To confirm the cell type of ES- derived fibroblasts and ES- 
derived cardiomyocytes, the dissociated fibroblasts and cardi-
omyocytes were seeded into Matrigel- coated 96- well plate at 
55,000 cells/well and maintained for at least 3 days. The cul-
ture was fixed with 4% paraformaldehyde (diluted in PBS) for 
12 minutes prior to being stored at 4°C for up to one week. On 
an experimental day, cells were incubated with 0.01% Triton 
X- 100 (diluted in PBS) for 15 minutes and washed twice in 
0.05% Tween 20 (diluted in PBS) to perforate membranes. 
Cells were then incubated in 5% human serum (diluted in 
PBS) for 30 minutes prior to antibody treatments. The fibro-
blast cultures were incubated for 1 hour with primary sheep 
anti- human CD90 antibody (No. AF2067, 1:50 dilution, R&D 
systems) and then 1 hour with secondary donkey anti- sheep 
AlexaFluor633 (No. A21448, 1:500 dilution, Thermo Fisher 
Scientific). The cardiomyocytes were incubated for 1  hour 
with primary mouse anti- human α- actinin antibody (No. 
A7811, 1:800 dilution, Sigma- Aldrich) and 1 hour with sec-
ondary goat anti- mouse AlexaFluor 488 (No. A11001, 1:1000 
dilution, Thermo Fisher Scientific). Both cell types were in-
cubated for 15 minutes with 0.5 µg/mL of DAPI (No. D9542, 
1:500 dilution, Sigma- Aldrich) to stain nuclear regions. 
Immunofluorescence images were captured with a 20x NA 
0.45 long working distance objective on an Operetta High- 
Content System (PerkinElmer, UK) with a 300  W Xenon 
lamp (360- 640  nm continuous spectrum) laser excitation. 
   | 5 of 20GOULDING et aL.
Excitation filter and emission bandpass filters were for DAPI 
380/40 and 445/70, AlexaFluor488 475/30 and 525/50 and 
for AlexaFluor633 630/20 and 705/110. Images were ana-
lyzed using Harmony High- Content Analysis software.
2.8 | Ligand- induced receptor 
internalization
Cells were plated at densities of 40  000 (HEK293T) or 
70  000 (ES progenitor) cells per well in poly- D- lysine/
Matrigel- coated black- walled, clear- bottomed 96 well 
Greiner plates in growth media and left overnight. The fol-
lowing day, the media was removed and cells were labeled 
with SNAP- 488 as described above. Following labeling 
the cells were washed once in imaging buffer (HBSS or 
modified ES:HBSS), and then incubated for 1h in imag-
ing buffer in the presence or absence of 100  µL formo-
terol (10  pM- 1  µM), salbutamol (100  pM- 100  µM) or 
salmeterol (1  pM- 10  µM). Buffer was then removed and 
cells washed once more in buffer and then fixed by in-
cubating in 10% ice- cold formalin solution (in PBS) for 
15 minutes prior to 10 minutes incubation in ice- cold PBS 
and a 15  minutes incubation in PBS containing 2  μg/mL 
of Hoechst 33342 stain. Cells were then washed once in 
PBS and then 100 µL PBS replaced per well and the 96- 
well plate was wrapped in foil and stored at 4°C for at 
least 24h. Four confocal images were recorded per well on 
the Molecular Devices ImageXpress Ultra confocal plate 
reader (Molecular Devices, CA) equipped with a Plan Fluor 
40x NA 0.6 extra- long working distance objective using 
405 nm laser excitation with a 477/60 band pass filter (to 
image Hoechst 33342) and 488 nm laser excitation with a 
525/50 band pass filter (to image SNAP- 488). The images 
were analyzed using the granularity analysis algorithm 
within the MetaXpress software (Molecular Devices, CA) 
which identifies fluorescent species, “granules,” defined 
by a fluorescence intensity threshold and size limits. Size 
limits detailing SNAP- labeled receptor or Hoechst 33342 
stained nuclear regions, for both cell types are as follows. 
HEK293T; receptor 7- 15 µm in width and nuclear regions 
6- 9 µm in width. ES; receptor 1- 3 µm in width and nuclear 
regions 5- 15 µm in width. As the intensity of these regions 
depended on the efficiency of their labeling, threshold 
background levels were set per plate and data were normal-
ized to allow comparison across experiments.
2.9 | Fluorescence correlation spectroscopy
Cells were plated on 8- well Nunc Lab- tek chambered 
coverglass (No. 1.0 borosilicate glass bottom) pre- coated 
with Matrigel (ES progenitor cells, cardiomyocytes), 
poly- D- lysine (HEK293T) or without coating (fibroblasts) 
in growth media and left at least 24h before analysis. Cells 
were labeled with SNAP- 488 (0.1 µM) for 30 minutes at 
37ºC and then washed twice in warm imaging buffer fol-
lowed by a longer 20  minutes wash before finally being 
left in 180 µL imaging buffer at 37ºC until use. Cells were 
then incubated in the absence or presence of the β2AR ago-
nist, formoterol (10  minutes, 10  nM, 37°C) before being 
allowed to cool to 24°C. FCS readings were taken on either 
a Zeiss LSM880 microscope on a Zeiss Axio Observer Z1 
stand (HEK293T) or on a Zeiss LSM510NLO ConfoCor 3 
microscope (ES progenitor cells, fibroblasts, cardiomyo-
cytes) both fitted with 40X c- Apochromat 1.2 NA water- 
immersion objectives using an Argon laser at 488  nm 
excitation with emission collected through a 505- 610BP 
filter (LSM10NLO) or a 508- 691 BP (LSM880) and the 
pinhole set to 1 Airy unit as previously described.54 Briefly, 
the detection volume was positioned in x- y using a live 
confocal image and then in z following an intensity z- scan 
±2 µm (in 0.25 µm intervals) from the approximated mem-
brane position. For HEK293T cells, the detection volume 
was placed at the peak of the intensity z- scan and fluores-
cent fluctuations collected for 1 × 20- 30s at ~0.5 kW/cm2 
laser power. For ES and progenitor cells sequential 1 × 20- 
30s reads at ~0.5 kW/cm2 laser power were taken at suc-
cessively decreasing z positions (0.25- 0.50  µm intervals) 
on the same cell and the membrane trace was identified 
from the first trace to show typical membrane fluctuation 
patterns and the associated autocorrelation curves.
Autocorrelation curves were analyzed within Zen Black 
(2012) software and fitted with a diffusion model consisting 
of two components, the first depicting a 3D (free SNAP) and 
the second a 2D (receptor) diffusing component.42 The auto-
correlation function (G(τ)) in relation to a fluorescent species 
diffusing through a 3D Gaussian detection volume can be de-
fined as follows:
where;
G () is the normalized intensity autocorrelation function 
which describes N number of fluorescent particles where fi 
is the fraction of the species, i, of a total m, having a dwell 
time of τDi. A is a pre- exponential factor to account for the 
photophysics of the fluorphore where
T which is the percentage of molecules in the trip-
let state and τT is the lifetime of the triplet state.
39 S is the 




















(2)A = 1 + T
1 − T
e− ∕T
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structure parameter that represents the ratio of the vertical 
to the radial axis of the confocal volume and can be deter-
mined experimentally.54 Considering that the diffusion of the 
SNAP- tagged β2AR is limited to the 2D plane of the plasma 
membrane, S → ∞ and Equation (1) simplifies to;
We used a combination of Equations (1) and (3) to 
model a diffusion profile to describe a first component de-
picting free SNAP- 488 (confined to that of free SNAP- 488, 
τD1  =  20- 80  µs) and a second component that represented 
the membrane receptor- bound SNAP- 488 (τD2). Where nec-
essary, an offset, k, was included to allow the autocorrelation 
curve to be fitted with an asymptote of >1. This is commonly 
seen where there is global photobleaching in the fluorescence 
fluctuations, for instance, due to a high immobile receptor 
fraction, or membrane movement within the volume, which 
results in a curve transposed in y. On average the offset was 
0.16 ±0.04% of the measured amplitude, reads were excluded 
if the offset was > 5% of the amplitude, or if an asymptotic 
value had not been reached. For the trace reads collected from 
the HEK293T lines, the initial 5  s were discarded prior to 
modeling to compensate for the bleaching of the fluorophore.
The precise radial and vertical axes of the confocal obser-
vation volume were determined on each experimental day by 
measuring the diffusion of 20 nM Rhodamine 6G as previ-
ously described.54
Fluorescence fluctuation measurements were also ana-
lyzed using PCH (photon counting histogram) within Zen 
Black (2012) software. PCH analysis reports the average 
molecular brightness of the measured population and can be 
used to define whether single (one- component) or multiple 
brightnesses were present.55 PCH uses a frequency distribu-
tion of photon counts within a defined time bin. A time bin 
of 0.1 ms was applied to all raw traces, appropriate for the 
diffusion speed of the membrane protein SNAPβ2AR being 
studied and analyzed. PCH histograms were fitted to either a 
one- or two- component PCH model which was determined 
by goodness of fit criteria at higher photons per bin values, 
with the data displayed on a linear- log scale. A system- 
dependent first- order correction was used, which accounts 
for photons detected outside of a true Gaussian detection vol-
ume, determined from the calibration data using Rhodamine 
6G and was set at 0.3 for the Zeiss LSM510NLO ConfoCor 3 
microscope and 0.6 for the Zeiss LSM880.
2.10 | Data analysis
Determination of agonist potency, antagonist affinity, and 
equilibrium dissociation constants were made by fitting data 
within GraphPad Prism version 7 for Windows (GraphPad 
Software, San Diego California USA, www.graph pad.com).
Statistical significance was determined, where appropri-
ate, using Mann- Whitney, one- way/two- way ANOVA, and 
Kruskal- Wallis with Tukey or Dunn's multiple comparison 
test if P < .05 (statistically significant). A minimum of three 
independent experiments was chosen for all experimental 
work. This was based on the variance of the data obtained 
and power analysis that predicted a high probability of ob-
serving small differences in measured parameters. For ex-
ample, the probability of detecting a change in pEC50 of 0.5 
(3- fold) with n = 3 is 0.89. For n = 4 this increased to 0.96.
2.11 | Ligands, chemical reagents, and 
other materials
Streptavidin paramagnetic beads were purchased from 
Promega (Wisconsin, USA). Blasticidin, StemPro34, Activin 
A, RPMI, GlutaMAX, B27, secondary antibodies, Essential 
8 Medium, and the Nunc Lab- tek chambered coverglass 
(155411) were purchased from Thermo Fisher Scientific 
(Paisley, UK). BMP4 and anti- CD90 were purchased from 
R&D systems (Minneapolis, USA). DMEM, FBS, PBS, 
NEAA, trypsin, poly- D- lysine, CGP 12177, CGP 20712A, 
ICI 118551, propranolol, salmeterol, salbutamol, Hoechst 
33342, DAPI, anti α- actinin, and formalin were purchased 
from Sigma- Aldrich (Missouri, USA). bFGF was pur-
chased from PeproTech (London, UK). Matrigel (#356235) 
was purchased from Corning (New York, USA). Black and 
white 96- well plates were purchased from Greiner bio- one 
(Kremsmunster, Austria). Formoterol and isoprenaline were 
purchased from Tocris Bioscience (Bristol, UK). 3H- CGP 
12177 and MicroScint 20 were purchased from PerkinElmer 
(Massachusetts, USA). SNAP- Surface Alexa Fluor 488 was 
purchased from New England Biolabs (Hitchin, UK). All 
other chemicals were purchased from Sigma- Aldrich.
The HUES7 cell line was a kind gift by Chad Cowan and 
Doug Melton.51 The BL15 was provided by David Darling.56 
The HEK293T cell line was obtained from the American 
Type Culture Collection (CRL- 11268).
3 |  RESULTS
3.1 | Characterization of ES cell progenitor 
cells expressing SNAPβ2AR
Relative expression levels and equilibrium dissociation con-
stants determined from radioligand- binding with 3H- CGP 
12177 were similar for the four ES progenitor cell lines ex-
pressing different haplotypes of SNAPβ2AR (P >  .05 one- 
way ANOVA, Figure  1, Table  1). The non- transgenic ES 
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cells displayed negligible- specific binding of 3H- CGP 12177 
(data not shown). Whole- cell competition binding displayed 
typical β2AR pharmacology in all four ES cell lines with high 
affinity for propranolol, CGP 12177, and the β2AR selective 
antagonist ICI 118551 and low affinity for the β1AR selec-
tive antagonist CGP 20712A (Figure 2, Table 1). Similar re-
sults were observed when the SNAPβ2AR constructs were 
stably expressed in HEK293T cells (Table 1).
Confocal imaging of the SNAPβ2AR expressed within the 
ES cell lines showed that membrane localization of the recep-
tor could be clearly defined and underwent agonist- induced 
internalization (Figure 3). A membrane- impermeable SNAP- 
tag substrate was used to label the receptor and therefore any 
intracellular receptor must have predominantly originated from 
the cell surface. Unstimulated ES progenitor cells expressed 
the SNAPβ2AR at the cell surface but there was also clear ev-
idence of constitutive receptor internalization (Figure 3A,C). 
Internalized receptor appeared to exist as clustered multiple 
small granules in contrast to the larger clusters of merged 
granules observed within the transgenic HEK293T cell 
lines (Supporting Information Figure S2). Agonist- induced 
internalization was clearly observed following 30  minutes 
treatment with 1 µM formoterol although high levels of recep-
tor also remained on the cell membrane (Figure 3B,D). Very 
similar receptor localization was observed across the four 
transgenic ES cell lines in the presence and absence of the 
βAR agonist formoterol. Non- transgenic ES cells displayed no 
discernible SNAP labeling (data not shown).
3.2 | Quantitative evaluation of agonist- 
induced receptor internalization using high 
content screening
To determine agonist concentration- response relationships 
for ligand- induced internalization of the SNAPβ2AR, we un-
dertook high content confocal imaging of the four haplotypes 
as described in Section 2.8 (Figure 4). Agonists displayed the 
same rank order of potency in the four ES transgenic lines with 
the two partial agonists salbutamol and salmeterol produc-
ing lower maximal responses than the full agonist formoterol 
(Table 2; Figure 4). Internalization in response to salmeterol 
F I G U R E  1  Whole- cell saturation binding of 3H- CGP12177 in ES progenitor cell lines stably expressing SNAPβ2AR. Representative 
experiments demonstrating 3H- CGP12177 binding in the presence (open circle) or absence (filled circle) of 10 μM propranolol in cells expressing 
the four different SNAPβ2AR haplotypes: A, Arg16Gln27 (RQ); B, Arg16Glu27 (RE); C, Gly16Gln27 (GQ) and D, Gly16Glu27 (GE). Data 
represent mean ± SEM of quadruplicate determinations in a single experiment. Similar data were obtained in 3- 4 separate experiments (Table 1)
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and salbutamol was quite varied and, apart from the cell line 
expressing the Arg16Gln27 (RQ) haplotype of SNAPβ2AR, 
there were some experiments where there was no response to 
salbutamol, salmeterol or both (Table 2). The EC50 values for 
salmeterol and salbutamol were only determined from those 
experiments that produced a measurable response and these 
were very similar across the haplotypes (two- way ANOVA, 
P > .05). Basal levels of internalization per cell were similar 
across all haplotypes for the separate cell types (P > .05, one- 
way ANOVA). The internalization achieved with salbutamol 
was greatest for the RQ haplotype in both ES cells (Figure 4; 
Table  2; P  <  .05, two- way ANOVA) and HEK293T cells 
(Supporting Information Figure S3, Table 2).
3.3 | Reduced expression of SNAPβ2ARs 
following the differentiation of ES progenitor 
cells into fibroblasts and cardiomyocytes
Following the differentiation of human ES cells into 
fibroblasts or cardiomyocytes (confirmed with the 
fibroblast marker Thy- 1 (CD90) and the cardiomyocyte marker 
α- actinin; Supporting Information Figure S1), the expression 
of SNAP- labeled receptors was markedly reduced (Figure 5). 
Only diffuse membrane labeling was observed in differenti-
ated fibroblasts (Figure 5A- D), while SNAPβ2AR was not 
detectable within the CM populations using confocal imag-
ing (Figure 5E,F). Fibroblasts did, however, display constitu-
tive receptor internalization (Figure 5C). However, following 
treatment with formoterol (10  nM, 20  minutes) no major 
difference in the extent of membrane expression or intracel-
lular granules was observed in the differentiated fibroblasts 
(Figure 5B,D).
3.4 | The use of FCS to study GPCR 
dynamics at low receptor expression levels
In order to quantify the expression of the SNAPβ2AR fusion 
protein at the cell membrane and study its dynamics in these 
low- expression systems, we employed fluorescence correla-
tion spectroscopy (FCS). FCS monitors fluorescently labeled 
Haplotype
RQ RE GQ GE
pKi pKi pKi pKi
ES progenitor cells
Propranolol 8.37 ± 0.02 (3) 7.94 ± 0.28 (3) 8.29 ± 0.06 (4) 8.30 ± 0.06 (4)
CGP 12177 8.54 ± 0.08 (3) 8.17 ± 0.26 (3) 8.59 ± 0.06 (4) 8.49 ± 0.10 (4)
ICI 118551 8.54 ± 0.06 (3) 8.12 ± 0.16 (3) 8.34 ± 0.04 (4) 8.21 ± 0.09 (4)
CGP 20712A 5.85 ± 0.26 (3) 5.90 ± 0.18 (3) 5.82 ± 0.14 (4) 5.76 ± 0.03 (4)
HEK 293T cells
Propranolol 8.44 ± 0.05 (3) 8.31 ± 0.05 (4) 8.42 ± 0.05 (4) 8.45 ± 0.03 (4)
CGP 12177 8.69 ± 0.05 (3) 8.61 ± 0.04 (4) 8.63 ± 0.08 (4) 8.67 ± 0.07 (4)
ICI 118551 8.33 ± 0.02 (3) 8.25 ± 0.05 (4) 8.37 ± 0.06 (4) 8.40 ± 0.09 (4)
CGP 20712A 5.29 ± 0.07 (3) 5.22 ± 0.16 (4) 5.75 ± 0.18 (4) 5.54 ± 0.15 (4)
T A B L E  1  Binding affinities (pKi) 
obtained for the four SNAPβ2AR 
haplotypes expressed in ES progenitor 
cells or HEK293T cells from inhibition 
of the specific binding of 3H- CGP 12 177 
(0.5- 1.5 nM). Determined pKi values 
were not significantly different across the 
haplotypes (P > .05, 1- way ANOVA). Data 
are expressed as mean ± SEM of n separate 
experiments. The number of separate 
experiments is given in parentheses. KD 
values obtained for 3H- CGP 12177 binding 
in each ES progenitor cell line were: RQ, 
1.94 ± 0.47 nM (4); RE 3.60 ± 1.13 nM (4); 
GQ 2.44 ± 0.58 nM (4); GE 5.77 ± 1.87 nM 
(4). KD values in HEK293T cell lines were: 
RQ 0.96 ± 0.12 nM (6); RE 1.11 ± 0.17 nM 
(6); GQ, 1.27 ± 0.22 nM (6); GE 
1.77 ± 0.34 nM (6)
F I G U R E  2  Inhibition of the binding 
of 3H- CGP12177 (1 nM) by CGP 20712A 
(closed circles), ICI 118551 (closed 
triangle), CGP 12177 (open triangle), and 
propranolol (open circle) in ES progenitor 
cells expressing the Gly16Gln27 haplotype. 
Data represent mean ± SEM of triplicate 
determinations in a single experiment. 
Similar results were obtained in three further 
experiments (Table 1)
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species as they pass through a small confocal volume (0.2 fl, 
0.2 μm2 of membrane)40 which can be placed within a defined 
region of the cell membrane. This method allows not only 
the quantification of such parameters as particle number per 
area (N/µm2), but also provides a measurement of their aver-
age diffusion coefficient (D, µm2s−1). FCS works particularly 
well in low expressing systems where greater sensitivity is 
imparted by the larger fluctuations in fluorescence caused by 
low fluorescent particle numbers.40 As a proof of principle, 
we optimized our protocol by studying the SNAPβ2AR in a 
low expression system using a CRISPR/Cas9 genome engi-
neered HEK293T cell line that expressed the SNAP- tagged 
β2AR under endogenous promotion. These data were com-
pared with those obtained in HEK293T cells overexpress-
ing the SNAPβ2AR following lentiviral transfection. Similar 
to the SNAPβ2AR in differentiated cardiomyocytes, the 
SNAPβ2AR within the CRISPR/Cas9 edited cells could not 
be visualized by standard confocal imaging (data not shown). 
It was possible, however, to measure fluorescence fluctua-
tions on the cell membrane using FCS (Figure 6A). The count- 
rate (Hz) was 20 to 30- fold greater in the overexpressing cell 
line compared to the CRISPR/Cas9 genome- edited cells and 
this resulted in significant bleaching in the overexpression 
line (Figure 6B). As a consequence, the first 5 seconds of the 
fluctuation trace were excluded from all measurements before 
the analysis of autocorrelation curves. Autocorrelation curves 
were constructed from these fluctuation traces (Figure 6C,D) 
and illustrate the difference in expression level where G(0) is 
inversely proportional to N. Fitting of these curves showed that 
two distinct diffusing populations could be resolved with dif-
ferent dwell times in the measurement volume (Figure 6C,D). 
The faster- diffusing component (dwell time τD1; 20- 80 µs) was 
consistent with free unbound SNAP- 488 dye diffusing within 
the detection volume.43 The slower diffusing component (τD2) 
represented the SNAPβ2AR expressed on the cell membrane. 
The diffusion coefficient (D) of this second component, how-
ever, was very similar between cell lines (Figure 6F, CRISPR: 
0.12 ± 0.01, n = 24; OE: 0.10 ± 0.01 µm2s−1, n = 30, respec-
tively). The particle number recorded from the CRISPR/Cas9 
edited cells for the SNAPβ2AR (37.4 ± 8.4 N/µm2, n = 24) 
was significantly lower than that seen in the over- expressing 
(OE) cells (349.1 ± 39.0 N/µm2, n = 30, Figure 6E, unpaired 
t test P < .0001). Fluctuations traces were then analyzed by 
photon counting histogram analysis (PCH) which reports the 
average molecular brightness of the measured population and 
can be used to define whether a single (one- component) or 
multiple brightnesses are present. An increase in brightness 
can indicate clustering or oligomerization of the tagged- 
species potentially as a result of membrane reorganization 
prior to GPCR internalization.43 All HEK293T traces fitted 
F I G U R E  3  Confocal imaging of ES 
progenitor cells expressing the Gly16Gln27 
(GQ) SNAPβ2AR haplotype following 
labeling with 0.5 µM surface- SNAP- 
Alexafluor488. Constitutive internalization 
can be observed in unstimulated cells (A) 
and inset (C). Increased internalization is 
observed following stimulation with 1 µM 
formoterol, 30 minutes (B), and inset (D). 
Multiple intracellular granules are observed 
which appear to form clusters (arrows) 
but high membrane localization is also 
still observed. Images are representative 
of images collected from at least three 
independent experiments
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to a one- component photon counting histogram (PCH) with 
the overexpression (OE) cell line exhibiting a significantly 
higher molecular brightness (ε, counts per molecule (cpm) 
per second; Supporting Information Figure S4, CRISPR: 
20 728 ± 2730 cpm.s−1, n = 24; OE: 34 620 ± 3322 cpm.s−1 , 
n = 30; P < .01 un- paired t test).
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3.5 | FCS measurements in ES progenitor 
cells and ES- derived fibroblasts and 
cardiomyocytes
The use of FCS in human ES cells and derived cell types re-
quired additional steps to locate the cell membrane (Figure 7). 
Typically the upper membrane of a cell expressing a SNAP- 
labeled membrane receptor can be identified as the peak of 
a z- intensity scan; however, this was not the case for the ES 
and derived cell types. The non- uniform nature of these cells 
coupled with the short sampling time meant that fluctuation 
traces which most closely described the apical membrane 
could be located up to 1 µm above this peak. Primary cells are 
routinely non- uniform and in the case of the cells, we have 
studied here, very thin. While the waist of the confocal vol-
ume is around 0.25 µm in diameter the vertical axial range is 
closer to 1 µm. A confocal volume, therefore, placed on a thin 
primary cell could theoretically encompass both apical and 
basal membranes. To ensure we could capture the trace that 
most closely represented that of the apical membrane we took 
sequential 20- 30 seconds trace reads every 0.25 µm through 
the cell starting above the cell membrane (Figure 7B,D). The 
first trace showing clear membrane- related fluctuations was 
used to determine membrane diffusion properties of the re-
ceptor. Two distinct decay populations could be resolved re-
lating to the SNAP- 488 within these progenitor cells similar 
to those observed in HEK293T cells (Figure 7E).
Single point FCS was carried out on ES progenitor cells, dif-
ferentiated ES- derived fibroblasts, and ES- derived cardiomyo-
cytes expressing the GQ variant of SNAPβ2AR to determine 
relative membrane particle number and diffusion properties of 
the SNAPβ2AR (Figure 8). Fluorescence fluctuations could be 
detected in all three cell types and traces representing the apical 
membrane could be readily identified (Figure 8A- C). Two dis-
tinct diffusing species could be detected in all three transgenic 
cell types (Figure 8D- F). The drop in receptor expression level 
observed using confocal microscopy was confirmed using FCS 
where the average particle number recorded from the ES- GQ 
cells (186.8 ± 33.2 N/µm2, n = 14) was significantly greater 
than that seen in differentiated GQ fibroblasts (60.6 ± 10.9 N/
µm2, n  =  28) and GQ cardiomyocytes (26.1  ±  4.6  N/µm2, 
n = 23) (Figure 8G, Kruskal- Wallis, fibroblasts P < .01, car-
diomyocytes P < .0001). The diffusion coefficients (D) were, 
however, very similar between cell types (Figure 8H; ES cells, 
0.054  ±  0.005 µm2s−1 (n  =  14); fibroblasts, 0.055  ±  0.004 
µm2s−1 (n = 28) and cardiomyocytes, 0.052 ± 0.005 µm2s−1 
(n  =  23); Kruskal- Wallis, P  >  .05). The majority of traces, 
from all cell types (ES; 92.9%, fibroblasts; 75%, cardiomy-
ocytes; 95.7%), fitted to a one- component fit with a bright-
ness consistently <16 000 cpm.s−1 (Figure 8I). The minority 
of traces fitted to a multiple component fit consisting of two 
distinct brightnesses, the first being <16  000  cpm.s−1 and 
the second being >16 000 cpm.s−1 (Figure 8I). The average 
molecular brightness (ε) was unaffected (Figure 8I; ES cells 
6577 ± 920 cpm.s−1 (n = 14); fibroblasts 5197 ± 396 cpm.
s−1 (n = 28); cardiomyocytes 6074 ± 866 cpm.s−1 (n = 23); 
Kruskal- Wallis, P > .05).
3.6 | Monitoring receptor internalization 
using FCS
While high- content imaging provides a powerful method-
ology to study agonist- internalization of SNAPβ2ARs in 
cells, FCS analysis allowed us to investigate the effect of 
an agonist in a membrane micro- domain of single living 
cells. ES- derived fibroblasts did not show agonist- induced 
internalization when monitored using confocal micros-
copy. To confirm this finding we undertook FCS studies 
on ES- derived fibroblasts using the SNAPβ2AR- RQ hap-
lotype. The RQ haplotype was chosen since it consistently 
responded to agonist challenge with the highest level of 
receptor internalization in ES progenitor cells (Figure 4). 
In keeping with the observations made using confocal mi-
croscopy (Figure 5), agonist treatment (10 minutes, 10 nM 
formoterol) had no significant effect on SNAPβ2AR- RQ 
particle number (N/µm2) in ES- derived fibroblasts 
(Figure  9A, Control; 173.2  ±  23.8, n  =  21. Formoterol; 
150.3 ± 24.6, n = 22, Mann- Whitney, P >  .05). The dif-
fusion coefficient (D, µm2s−1) was also unaffected by 
agonist treatment (Figure  9B. Control, 0.041  ±  0.003, 
n  =  21; Formoterol, 0.043  ±  0.004, n  =  22, Mann- 
Whitney, P > .05). Finally, the traces were also subject to 
PCH analysis to determine the average molecular bright-
ness (ε). All traces fitted to a one- component PCH with 
no significant change observed following formoterol treat-
ment (Figure  9C, Control; 6939  ±  891  cpm.s−1, n  =  21. 
Formoterol; 6901 ± 633 cpm.s−1, n = 22).
To confirm that we were able to observe agonist- 
induced changes in the parental ES progenitor cells within 
F I G U R E  4  Quantification of agonist- induced internalization of SNAPβ2AR in ES progenitor cells expressing the four different haplotypes: 
A, Arg16Gln27 (RQ); B, Arg16Glu27 (RE); C, Gly16Gln27 (GQ) and D, Gly16Glu27 (GE). A- D, Single experiments (n = 6- 9) were performed 
with duplicate determinations and plotted data represent mean ± SEM of the number of SNAP- 488 labeled granules expressed as a percentage of 
that obtained with 1 µM formoterol after 1 hour stimulation with βAR agonists; formoterol (red circle), salmeterol (green square) and salbutamol 
(blue triangle). EC50 and EMAX values alongside the number of separate experiments performed are provided in Table 2. Derived Emax values 
(mean ± SEM, n = 6- 9) for salbutamol (E, blue) and salmeterol (F, green) are also shown. Raw data were subject to 2- way ANOVA with Tukey's 
multiple comparison test; *P < .05, **P < .01
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the membrane using single point FCS, we studied the ES- 
SNAPβ2AR- RQ progenitor cell line which exhibited agonist- 
induced internalization using both confocal imaging and high 
content imaging (Figures 3 and 4). ES- SNAPβ2AR- RQ cells 
subject to formoterol treatment (10 minutes, 10 nM formo-
terol) displayed significantly reduced SNAPβ2AR particle 
numbers (Figure  9D, 143.8  ±  23.1  N/µm2, n  =  27) com-
pared to those treated with vehicle (341.9  ±  60.0  N/µm2, 
n = 27. Mann- Whitney, P < .01). The diffusion coefficient 
(D, µm2s−1) of the SNAPβ2AR was, however, not affected by 
agonist treatment (Figure 9E; control, 0.045 ± 0.004, n = 27; 
formoterol treatment, 0.039  ±  0.003, n  =  27). In contrast, 
the molecular brightness (ε) of all traces fitted to a one- 
component PCH and was significantly increased following 
formoterol treatment (Figure 9F; control; 3061 ± 415 cpm.
s−1, n = 26; formoterol, 4121 ± 531 cpm.s−1, n = 27. P > .05). 
These data suggest that the SNAPβ2AR- RQ is clustering on 
the cell membrane in ES progenitor cells prior to internaliza-
tion following agonist treatment.
The particle number in ES- derived fibroblasts, under 
control conditions, appeared to be dependent on haplotype, 
GQ (Figure 8; 60.61 ± 10.89 N/µm2, n = 28) being lower 
than that of RQ (Figure  9; 173.2  ±  23.8  N/µm2). In order 
to check that the lack of internalization in ES- derived fibro-
blasts was not due to haplotype, we undertook a second se-
ries of experiments in ES- derived fibroblasts expressing the 
GQ haplotype (Figure 9G- I). Particle number was of a sim-
ilar order to that previously measured, reduced compared to 
that observed in the RQ ES- derived fibroblasts and not sig-
nificantly affected by formoterol treatment (Figures 9G and 
10; control, 99.7 ± 15.1, n = 20; formoterol, 128.0 ± 15.1 N/
µm2, n = 19; P >  .05). This was also the case for the mo-
lecular brightness (control; 4803  ±  374  cpm.s−1, n  =  20; 
formoterol, 5876 ± 653 cpm.s−1, n = 19; P > .05) and diffu-
sion coefficient (control; 0.040 ± 0.004, n = 20; formoterol, 
0.048 ± 0.005 µm2s−1, n = 19; P > .05).
4 |  DISCUSSION
In the present study, we have used a combination of FCS and 
ES cell technology to investigate the impact of cell differ-
entiation on receptor mobility and internalization in human 
ES progenitor cells and in ES- derived cardiomyocytes and 
fibroblasts. We generated four different ES progenitor cells 
expressing SNAP- tagged β2- adrenoceptors with one of the 
four haplotypes involving single- nucleotide polymorphisms 
at position 16 (arginine or glycine) and position 27 (glu-
tamine or glutamate). All expressed the SNAPβ2AR to a 
similar level and all four haplotypes could be internalized 
in response to the full agonist formoterol, as determined by 
high content confocal imaging. Salmeterol and salbutamol 
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of salbutamol, there was a significantly greater internaliza-
tion in the RQ (Arg16Gln27) expressing cells compared to 
cells expressing the other three haplotypes. Positions 16 and 
27 are both within the extracellular N- terminal region of the 
receptor that has been implicated in the regulation of recep-
tor recycling and down- regulation.17- 20 In agreement with 
the data presented here, previous in vivo cardiovascular ex-
periments in human volunteers have linked the RQ haplotype 
with enhanced receptor desensitization, while the GE hap-
lotype produces a blunted susceptibility to agonist- induced 
desensitization.57,58
A striking feature of the initial experiments performed 
with ES- derived cardiomyocytes and fibroblasts was that the 
expression of SNAP- tagged β2- adrenoceptors dropped dra-
matically following the differentiation process. Although the 
receptor was still detectable in ES- derived fibroblasts, this 
was not the case with ES- derived cardiomyocytes where the 
SNAPβ2AR fluorescence could not be distinguished from 
background autofluorescence. One approach that has the sen-
sitivity to monitor receptors in membrane microdomains at 
very low receptor expression levels is FCS.40 FCS monitors 
fluorescently labeled species as they pass through a small con-
focal volume (0.2 fl, 0.2 μm2 of membrane)40 and allows the 
quantification of receptor expression in terms of fluorescent 
particle number (N/µm2) and their diffusion characteristics 
(D, µm2s−1). FCS works particularly well in low expressing 
systems where greater sensitivity is imparted by the larger 
statistical variation caused by low fluorescent particle num-
bers.40 As a consequence, the autocorrelation function G(τ) 
at τ = 0 is inversely proportional to the particle number.40
As a first step to apply FCS to study cell surface re-
ceptor expression in membrane microdomains of single 
ES- derived cells, we undertook a comparison of SNAP- 
tagged β2- adrenoceptors in HEK293T cells overexpressing 
F I G U R E  5  Confocal imaging of 
SNAPβ2AR in (A- D) human ES- derived 
fibroblasts expressing the Arg16Glu27 
haplotype or (E,F) human ES- derived 
cardiomyocytes expressing the Arg16Gln27 
haplotype. All cells were labeled with 
0.5 µM surface- SNAP- Alexafluor488. E, No 
visible SNAP labeling could be observed 
through standard confocal imaging of 
ES- derived cardiomyocytes; F, brightfield 
image is included to illustrate the presence 
of cells. While SNAPβ2AR could be imaged 
in ES- derived fibroblasts (A) and inset 
(C) it was not possible to identify agonist- 
induced internalization of receptor following 
formoterol (10 nM; 20 minutes) treatment 
(B, and inset (D)). A- D, Diffuse membrane 
expression could be observed, more 
strongly apparent at membrane- membrane 
boundaries (arrow).
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SNAPβ2AR following lentivirus transfection or in CRISPR/
Cas9 genome- edited HEK293T cells expressing SNAPβ2AR 
under endogenous promotion. In HEK293T cells, the en-
dogenous expression of β2- adrenoceptors is very low
59 and 
SNAPβ2ARs were not detectable by confocal microscopy 
in CRISPR/Cas9 genome- edited HEK293T cells. The use 
of FCS was, however, able to detect the large difference in 
expression levels (CRISPR cells, 37.4 particles per µm2; len-
tivirus over- expressing cells, 349.1 particles per µm2) with-
out a significant difference in the diffusion coefficient of the 
β2- adrenoceptor between the two cell types. Interestingly, 
the average molecular brightness of the diffusing fluorescent 
particles containing SNAPβ2ARs in over- expressing cells 
was significantly higher than that in the CRISPR/Cas9 
genome- edited cells. This perhaps indicates that the cluster-
ing of the β2- adrenoceptor is occurring at higher expression 
levels similar to the observation recently made for CXCR4, 
which forms transient homodimers at high receptor den-
sities.60 The difference in brightness of SNAPβ2ARs be-
tween overexpressed cells and CRISPR/Cas9 genome- edited 
HEK293 cells is approximately twofold. It has been previ-
ously reported that β2- adrenoceptors have a propensity to 
form dimers and higher order oligomers36 but at the present 
time, we cannot conclude whether the changes observed for 
F I G U R E  6  Fluorescence correlation spectroscopy of CRISPR/Cas9 edited HEK293T cells. Representative FCS traces taken on the cell 
membrane of (A) HEK293T cells that have been CRISPR/Cas9 genome- engineered to express SNAPβ2AR under endogenous promotion or (B) 
HEK293T cells overexpressing (OE) SNAPβ2AR. C, Autocorrelation analysis for CRISPR/Cas9 genome- edited cells and (D) OE cells. Raw (blue) 
and fitted data (green) are displayed. E, Individual mean particle number N/µm2 and (F) diffusion coefficient (D; µm2s−1) measurements are plotted 
for CRISPR (closed circles) and OE (open circles) cell lines. In (E) please note the different scales for the CRISPR and OE particle numbers. In (F) 
the mean ± SEM of all measurements (dotted line) are displayed for each cell line
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F I G U R E  7  Positioning the confocal volume on the cell membrane of ES or differentiated cell type. A, The FCS detection volume, depicted by 
the red crosshair intersect, is positioned on the live high- zoom confocal image of an ES- derived fibroblast expressing the Gly16Gln27 haplotype of 
SNAPβ2AR labeled with 0.1 μM surface- SNAP AlexaFluor488. The z- position of the upper membrane is approximated by eye, and bright clusters are 
avoided as these could represent immobile receptor. B, An intensity z- scan is recorded at low laser power at the crosshair, at 2 µm above and below the 
approximated position of the upper cell membrane (position 0.0 µm) in 0.5 µm steps. The FCS detection volume is moved to +1.5 µm above the peak 
intensity reading (eg, moved to position 0.5 µm). C, 1 × 30 seconds FCS trace reads are collected at experimental laser power every 0.25 µm moving 
toward the position of peak intensity. FCS trace reads obtained at the z positions displayed in (B) are shown. D, Autocorrelation curves are constructed 
for individual traces within Zen Black (2012) software. Curves are modeled with a 1 × 3D + 1 × 2D autocorrelation model which includes a triplet 
component and an offset to allow for membrane drift (see Section 2.9). Curves can be excluded for several reasons, including if the 2D component is too 
fast/slow to depict a membrane protein (purple trace), if the curve fails to reach a lower plateau or allowed offset is too great (red trace), or if the curve 
cannot be described by the model. The blue and green traces contain a membrane component; however, the blue trace is selected as this trace has a greater 
proportion of 2D vs 3D fluctuations. E, Autocorrelation curve and model for the selected blue trace. The 3D dwell time, τD1 = 74 µs and represents free 
surface- SNAP- AlexaFluor488, the 2D dwell time, τD2 = 146 ms and represents SNAP labeled SNAPβ2AR. Blue— raw data, green— fit model
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the β2- adrenoceptor reflect changes in monomer- dimer or 
dimer- higher- oligomer equilibria.
FCS was able to quantify the large difference in β2- 
adrenoceptor expression levels between ES progenitor cells 
expressing the Gly16Gln29 (GQ) haplotype (186.8 particles 
per µm2) and the equivalent ES- derived GQ fibroblasts (60.6 
particles per µm2) and ES- derived GQ cardiomyocytes (26.1 
particles per µm2). Diffusion coefficients were similar across 
all three ES cell lines (0.05 µm2s−1) and approximately half 
the value of the diffusion coefficients obtained in HEK293T 
cells (0.1 µm2s−1) indicative of their different membrane com-
positions and organizations. The particle number detected 
by FCS in ES- progenitor cells expressing the Arg16Gln27 
(RQ) phenotype (341.9 particles per µm2) was higher than 
in the equivalent GQ cells and following differentiation to 
ES- derived fibroblasts, the particle number (173.2 particles 
per µm2) was also higher than that detected in the equivalent 
GQ haplotype, but significantly lower than in the (RQ) ES- 
progenitor cells.
The RQ haplotype was chosen for studies of agonist- 
induced receptor internalization of SNAPβ2ARs using FCS 
since it consistently exhibited a robust agonist- induced recep-
tor internalization in ES progenitor cells when monitored by 
high content confocal imaging.
Following agonist treatment of ES progenitor cells (10nM 
formoterol, 10 minutes), the SNAPβ2AR- RQ haplotype dis-
played a significant reduction in cell surface particle num-
ber from 341.9 particles per µm2 to 143.8 particles per µm2 
F I G U R E  8  Cell membrane fluorescence correlation spectroscopy of human ES progenitor cells and differentiated fibroblasts and 
cardiomyocytes. Representative traces are shown for (A) ES progenitor cells, (B) ES- derived fibroblasts, and (C) ES- derived cardiomyocytes 
expressing the SNAPβ2AR with theGly16Gln27 haplotype. Autocorrelation traces (blue) and the resulting autocorrelation fit (green) are shown 
for (D) ES progenitor cells, (E) fibroblasts, and (F) cardiomyocytes. Individual experimental (G) membrane particle number N/µm2, (H) diffusion 
coefficients D (µm2s−1) and (I) molecular brightness ε, (cpm.s−1), are plotted with the mean (dotted line) ± SEM for ES (black closed circles), 
FIB (black open circles) and CM (orange closed circles). G, Average particle number recorded for ES progenitor cells is significantly greater 
than that recorded in ES- derived fibroblasts (P < .01) and ES- derived cardiomyocytes (P < .0001; Kruskal- Wallis). I, data were fitted to either a 
one- component or two- component PCH analysis and the first (1, left) and second (2, right) brightness values are plotted. For data that fit to a two- 
component analysis the second, brighter, population represented a small percentage of the total measured population; 5.1% (ES; n = 1), 5.7% (CM, 
n = 1) and 3.1% ± 0.9 (FIB, n = 7)
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F I G U R E  9  Fluorescence correlation spectroscopy to study the effect of formoterol (10 nM, 10 minutes) on ES- derived fibroblasts (A- C) 
and ES progenitor cells (D- F) expressing the Arg16Gln27 (RQ) haplotype of the SNAPβ2AR. Also shown are data for ES- derived fibroblasts 
expressing the Gly16Gln27 (GQ) haplotype (G- I). Data show particle number (A, D, G), diffusion coefficient (B, E, H), and molecular brightness 
(C, F, I). Measurements were made in the presence (black closed circles) or absence (black open circles) of formoterol (10 nM, 10 minutes). 
Grouped mean values (dotted line) ± SEM are also shown. P < *.05 and **.01, Kruskal- Wallis test
F I G U R E  1 0  Particle number data from Figure 9 are displayed on the same scale to allow comparison. Particle number, as determined by 
Fluorescence Correlation Spectroscopy, for ES- derived fibroblasts (A) and ES progenitor cells (B) expressing the Arg16Gln27 (RQ) haplotype and 
(C) ES- derived fibroblasts expressing the Gly16Gln27 (GQ) haplotype of the SNAPβ2AR. Measurements were made in the presence (black closed 
circles) or absence (black open circles) of formoterol (10 nM, 10 min). Grouped mean values (dotted line) + SEM are also shown. P < *0.05 and 
**.01, Kruskal- Wallis test
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which was consistent with agonist- induced receptor internal-
ization. The diffusion coefficients of the receptor- containing 
complexes were not affected by agonist treatment but their 
molecular brightness (ε) was significantly increased, sug-
gesting that there maybe clustering of β2- adrenoceptor on 
the cell membrane prior to internalization. It is notable that 
the brightness values observed in ES progenitor cells (and 
also fibroblasts and cardiomyocytes) were very much lower 
than those measured in HEK293 cells and this probably re-
flects the impact of the local cellular environment and fluo-
rescence quenching. The role of receptor clustering on the 
cell membrane has been reported previously in association 
with the internalization of particular GPCRs including the 
β2- adrenoceptor
43,61 and the 1.35- fold increase in brightness 
observed in ES progenitor cells probably equates to an in-
crease in the proportion of dimeric/oligomeric species as re-
ceptors are sequestered at sites of receptor endocytosis.
In marked contrast to the data obtained in ES progenitor 
cells, no significant reduction in particle number was evident 
in ES- derived fibroblasts following formoterol treatment in 
cells expressing either the Arg16Gln27 (RQ) or Gly16Gln27 
(GQ) haplotypes. These data were, however, consistent with 
the observations made in ES- derived fibroblasts expressing 
the RQ haplotype using confocal microscopy (Figure  5). 
Taken together these studies indicate that susceptibility to 
agonist- induced receptor internalization is dependent upon 
cell phenotype and can be changed following the differenti-
ation of ES progenitor cells into fibroblasts. This may have 
important implications for drug discovery where attempts 
are being made to introduce signaling bias into agonist mol-
ecules that can stabilize specific conformations of GPCRs 
and alter their ability to couple to G proteins or β- arrestin 
molecules.62 Reduced internalization will reduce the extent 
of signaling from intracellular endosomes.10,11 Furthermore, 
the differential sensitivity of different cell phenotypes to 
agonist- induced internalization of the β2- adrenoceptor may 
also have implications for drug therapy with inhaled long- 
acting β2- agonists.
63,64
In summary, the present study has demonstrated the 
power of FCS in investigating cell surface β2- adrenoceptors 
at the very low expression levels often seen in endogenously 
expressing cells. FCS was able to detect SNAP- tagged 
β2- adrenoceptor expression in both ES- derived cardiomy-
ocytes and CRISPR/Cas9 genome- edited HEK293T cells, 
where the expression level was too low to detect them using 
standard confocal microscopy. Furthermore, the use of ES cell 
technology in combination with FCS allowed us to demon-
strate that cell surface β2- adrenoceptors can be internalized in 
response to formoterol- stimulation in ES progenitor cells but 
not following their differentiation into ES- derived fibroblasts. 
This indicates that the process of agonist- induced receptor 
internalization is strongly influenced by cell phenotype and 
this may have important implications for drug treatment with 
long- acting β2- agonists.
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